Increased rate of hemangiomas linked to rise in number of low birth weight infants in US

October 20, 2008

Low birth weight is the most significant factor for the development of infantile hemangiomas, a common birthmark, according to a new study by researchers at The Medical College of Wisconsin and Children's Research Institute.

The study, led by Beth Drolet, M.D., professor of dermatology and pediatrics at the Medical College and medical director of pediatric dermatology and birthmarks and vascular anomalies clinic at Children's Hospital of Wisconsin, is published in the November 2008 issue of The Journal of Pediatrics.

"Hemangiomas are benign tumors composed of blood vessels. Our institution has seen a dramatic increase in the number of infants presenting for care with hemangiomas. We believe the results of this study provide an explanation for this emerging pediatric health issue," says Dr. Drolet.

While factors such as being female, Caucasian and premature birth have been previously identified as risk factors for hemangiomas, Dr. Drolet's study found that low birth weight was the most statistically significant risk factor.

"For every 1.1 pound decrease in birth weight, the risk of hemangioma increased by nine-fold," says Dr. Drolet.

Recently, there has been an increase in the U.S. of infants born under 5.5 pounds. In 2005, 8.2 percent of infants born in the U. S. weighed less than 5.5 pounds. This is the highest percentage recorded since 1968 and is higher than the rate in most industrialized countries.

Additionally, a dramatic increase in low birth weight has been found in white, non-Hispanic infants. Low birth weight has increased 38 percent since 1990 in this group.

"This study reaffirms several known risk factors for infantile hemangiomas, specifically female gender, white, non-Hispanic race/ethnicity, and prematurity," says Dr. Drolet. "But the link to low birth weight may explain why physicians believe more infants are developing hemangiomas. Based on low birth weight statistics, we estimate that the incidence of infantile hemangiomas has increased by 40 percent in the last 20 years."

The researchers compared 420 children who had been diagnosed with infantile hemangiomas at Children's Hospital of Wisconsin and the University of California – San Francisco Medical Center (UCSF) with 353 children less than two years old who had been diagnosed with skin anomalies other than infantile hemangioma.

Dr. Drolet and co investigator Dr. Ilona Frieden, professor of dermatology and pediatrics at UCSF, formed a 10-member research consortium to better study ways to prevent and treat infantile hemangiomas.

Earlier studies by the research consortium identified other risk factors for developing hemangiomas, including increased maternal age, maternal history of infertility, and assisted reproductive technologies. Children born to women who had experienced a miscarriage are also more likely to develop hemangiomas. Additionally, 33 percent of infants with hemangiomas had the disorder in their family histories.

While hemangiomas are amongst the most common birthmarks, their cause is not known. Infantile hemangiomas are not visible at birth, but become evident within the first few weeks of life. Because of this, they are less likely to be recorded in typical birth defect registries. Hemangiomas may result in permanent scarring or other medical issues that require treatment.

"The finding that a significantly higher percentage of children with infantile hemangiomas had a positive family history suggests at least some genetic predisposition," says Dr. Drolet.

There are currently no FDA-approved medical therapies for the treatment of infantile hemangiomas. Most treatments are limited, due to increasing the potential risk of scarring.

"We urgently need further research to evaluate existing medications so that more evidence-based approaches to management can be established," says Dr. Drolet. "Our study also underscores the need for continuing education of providers caring for children in distinguishing benign hemangiomas from those with the greatest potential for complications and need for treatment."

Source: Medical College of Wisconsin

Explore further: Infantile hemangioma incidence up over past three decades

Related Stories

Infantile hemangioma incidence up over past three decades

December 30, 2015
(HealthDay)—The incidence of infantile hemangiomas (IH) has increased over the past three decades, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

Propranolol seems prophylactic against infantile hemangiomas

March 17, 2015
(HealthDay)—Propranolol seems to be prophylactic against infantile hemangiomas, according to a case report published online March 16 in Pediatrics.

'Strawberry' birthmarks grow rapidly when babies just weeks old, study finds

August 14, 2012
Strawberry-shaped birthmarks called infantile hemangiomas grow rapidly in infants much earlier than previously thought, Mayo Clinic and University of California, San Francisco, researchers found. Their study, published online ...

Recommended for you

Drug found that induces apoptosis in myofibroblasts reducing fibrosis in scleroderma

December 15, 2017
(Medical Xpress)—An international team of researchers has found that the drug navitoclax can induce apoptosis (self-destruction) in myofibroblasts in mice, reducing the spread of fibrosis in scleroderma. In their paper ...

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

Time of day affects severity of autoimmune disease

December 12, 2017
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications. Understanding the effect of the interplay between ...

Estrogen discovery could shed new light on fertility problems

December 12, 2017
Estrogen produced in the brain is necessary for ovulation in monkeys, according to researchers at the University of Wisconsin-Madison who have upended the traditional understanding of the hormonal cascade that leads to release ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.